Your browser doesn't support javascript.
loading
[Complement inhibitors: A global point of view]. / Les inhibiteurs du complément : une vue d'ensemble.
Pogossian, A; de Moreuil, C; Lemarié, C; Rouvière, B; Delplanque, M; Molina, B; Prophette, L; Le Moigne, E.
Afiliação
  • Pogossian A; UMR 1304, GETBO, université de Bretagne Occidentale, Brest, France; Département de médecine interne, médecine vasculaire et pneumologie, CHU Brest, Brest, France. Electronic address: alexanpogossian@gmail.com.
  • de Moreuil C; UMR 1304, GETBO, université de Bretagne Occidentale, Brest, France; Département de médecine interne, médecine vasculaire et pneumologie, CHU Brest, Brest, France.
  • Lemarié C; UMR 1304, GETBO, université de Bretagne Occidentale, Brest, France.
  • Rouvière B; Département de médecine interne, médecine vasculaire et pneumologie, CHU Brest, Brest, France; UMR 1227, LBAI, université de Bretagne Occidentale, Brest, France.
  • Delplanque M; Département de médecine interne, médecine vasculaire et pneumologie, CHU Brest, Brest, France.
  • Molina B; Département de médecine interne, médecine vasculaire et pneumologie, CHU Brest, Brest, France.
  • Prophette L; Département de médecine interne, médecine vasculaire et pneumologie, CHU Brest, Brest, France.
  • Le Moigne E; UMR 1304, GETBO, université de Bretagne Occidentale, Brest, France; Département de médecine interne, médecine vasculaire et pneumologie, CHU Brest, Brest, France.
Rev Med Interne ; 43(12): 703-712, 2022 Dec.
Article em Fr | MEDLINE | ID: mdl-36460439
ABSTRACT
Innate immunity, and more specifically the complement system, has arised renewed interest in the medical field in recent years. Many innovative complement-inhibiting drugs have appeared, acting at various levels of the complement cascade. These drugs have made it possible to transform poor prognosis of certain diseases. Many of them are currently being tested in clinical trials for various indications. Many questions appear about their optimal use and their future indications. This article recalls the fundamental role of the complement system in the human organism. It then discusses the diseases in which the complement is involved on the pathophysiological level. The third part details the different classes of complement inhibitors and briefly recalls the indications for which these treatments seem the most promising. Finally, we end with a discussion that highlights the different aspects and questions induced by these new treatments.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inativadores do Complemento / Imunidade Inata Limite: Humans Idioma: Fr Revista: Rev Med Interne Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inativadores do Complemento / Imunidade Inata Limite: Humans Idioma: Fr Revista: Rev Med Interne Ano de publicação: 2022 Tipo de documento: Article